Molecule: Researcher takes another step toward discovering how a brain molecule could halt MS
Fractalkine appears to trigger repair of brain damage caused by the disease. Alberta, Jan 23, 2023.- A University of Alberta researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases. MultipleContinuar Leyendo



















